Tango Therapeutics TNGX
Last Price
52 Week Range
$1.03 - $13.48
Next Earnings Date
Feb 26 2026
Next Earnings Date
Feb 26 2026
Last Price
TNGX Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Tango Therapeutics, Inc. | 8-K | January 8, 2026 | |
Tango Therapeutics, Inc. | 8-K | January 5, 2026 | |
Tango Therapeutics, Inc. | 8-K | November 21, 2025 | |
Tango Therapeutics, Inc. | S3ASR | November 21, 2025 | |
Tango Therapeutics, Inc. | 10-Q | November 4, 2025 | |
Tango Therapeutics, Inc. | 8-K | November 4, 2025 | |
Tango Therapeutics, Inc. | 8-K | October 24, 2025 | |
Tango Therapeutics, Inc. | 8-K | October 23, 2025 | |
Tango Therapeutics, Inc. | 8-K | August 25, 2025 | |
Tango Therapeutics, Inc. | 8-K | August 5, 2025 | |
Tango Therapeutics, Inc. | 10-Q | August 5, 2025 | |
Tango Therapeutics, Inc. | 8-K | June 6, 2025 | |
Tango Therapeutics, Inc. | 10-Q | May 12, 2025 | |
Tango Therapeutics, Inc. | 8-K | May 12, 2025 | |
Tango Therapeutics, Inc. | DEFA14A | April 22, 2025 | |
Tango Therapeutics, Inc. | ARS | April 22, 2025 | |
Tango Therapeutics, Inc. | DEF 14A | April 21, 2025 | |
Tango Therapeutics, Inc. | PRE 14A | April 11, 2025 | |
Tango Therapeutics, Inc. | 10-K | February 27, 2025 | |
Tango Therapeutics, Inc. | 8-K | February 27, 2025 | |
Tango Therapeutics, Inc. | 8-K | January 13, 2025 | |
Tango Therapeutics, Inc. | 8-K | November 6, 2024 | |
Tango Therapeutics, Inc. | 10-Q | November 6, 2024 | |
Tango Therapeutics, Inc. | 10-Q | August 7, 2024 | |
Tango Therapeutics, Inc. | 8-K | August 7, 2024 | |
Tango Therapeutics, Inc. | 8-K | June 6, 2024 | |
Tango Therapeutics, Inc. | 8-K | May 23, 2024 | |
Tango Therapeutics, Inc. | 10-Q | May 8, 2024 | |
Tango Therapeutics, Inc. | 8-K | May 8, 2024 | |
Tango Therapeutics, Inc. | DEF 14A | April 29, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.